Factors influencing treatment delays for acute myocardial infarction

Mark W Bird1, Amanda G Woods, Nancy A Warren

  • 1Emergency Department, Sacred Heart Medical Center-University District, Eugene, Oregon 97401, USA.

Insights

Delaying acute myocardial infarction treatment increases risks. Gender, culture, and socioeconomic factors influence delays, hindering access to life-saving therapies like reperfusion.

Area of Science:

  • Cardiology
  • Public Health
  • Health Disparities

Background:

  • Delayed medical attention for acute myocardial infarction (AMI) is linked to severe complications, including cardiac dysrhythmias, heart failure, and structural damage.
  • Factors such as gender, cultural background, and socioeconomic status significantly influence patient decisions and timeliness in seeking treatment for AMI.
  • These delays can impede the administration of crucial occlusion-eliminating therapies, potentially worsening patient outcomes.

Purpose of the Study:

  • To initiate a discussion on the impact of delayed treatment for acute myocardial infarction (AMI).
  • To explore how gender, cultural factors, and socioeconomic status contribute to treatment delays.
  • To examine the consequences of these delays on the effectiveness of occlusion-eliminating therapies.

Main Methods:

  • This article presents a discussion based on existing literature and clinical observations.
  • It synthesizes findings from previous studies on AMI treatment delays and associated factors.
  • The focus is on analyzing the interplay between patient demographics, cultural influences, socioeconomic barriers, and therapeutic interventions.

Main Results:

  • Delayed treatment for AMI is associated with increased risks of serious cardiac complications.
  • Gender, cultural norms, and socioeconomic status are identified as significant barriers to timely AMI care.
  • Delays negatively affect the opportunity to administer timely and effective occlusion-eliminating therapies.

Conclusions:

  • Addressing gender, cultural, and socioeconomic factors is crucial to reduce AMI treatment delays.
  • Timely intervention is vital for improving outcomes and maximizing the benefits of reperfusion therapies.
  • Further research is needed to develop targeted strategies to overcome these barriers and improve AMI patient care.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...